Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZOM stock price vs BGC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BGC's multiple
Needs BGC P/S.
Implied fair value · at ZOM's multiple
Needs Revenue / share, ZOM P/S.
Snapshot Sep 9, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zomedica Corp. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
BGC Group, Inc. · implied price per share
Bear
$6.99
Base
$8.48
Bull
$10.43
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoetis Inc.
ZOM vs ZTS
Elanco Animal Health Inc
ZOM vs ELAN
PHIBRO ANIMAL HEALTH CORP
ZOM vs PAHC
Moelis & Co
ZOM vs MC
PIPER SANDLER COMPANIES
ZOM vs PIPR
RAYMOND JAMES FINANCIAL INC
ZOM vs RJF
MARKETAXESS HOLDINGS INC
ZOM vs MKTX
Interactive Brokers Group, Inc.
ZOM vs IBKR
LPL Financial Holdings Inc.
ZOM vs LPLA
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
